RE:RE:Size & share of the US Dialysis market ? MM,
Solid work as usual... Boring but solid.
Although the multiple for Spectral, with Dialco now an astonishingly successful commercial venture, is around 0.02 without giving it much thought and being aggressive at that, I understand that biotech multiples as a whole are on the rise.
25 times Earnings might be back in play... yet here we languish with absolutely ZERO linkage between reality and share price...NONE!
Can't wait to see the takeout number for Dialco. I think it may have doubled off today's news... and many, many more like it in the works!